Stockhub

Luye Pharma Group Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 August 2022

  • curprev 03:0103:01, 28 August 2022 >Nick 2,095 bytes +2,095 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for..."
Retrieved from "https://stockhub.co/research/Luye_Pharma_Group_Ltd."